CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV.
Publication
, Conference
Kuhn, SA; Marosi, C; Pabinger, I; Bullinger, L; Goldbrunner, R; Khorana, AA; Ahluwalia, MS; Rickles, FR; Lyman, GH; Vajkoczy, P
Published in: Journal of Clinical Oncology
May 20, 2015
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
TPS2079 / TPS2079
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kuhn, S. A., Marosi, C., Pabinger, I., Bullinger, L., Goldbrunner, R., Khorana, A. A., … Vajkoczy, P. (2015). CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV. In Journal of Clinical Oncology (Vol. 33, pp. TPS2079–TPS2079). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.tps2079
Kuhn, Susanne Antje, Christine Marosi, Ingrid Pabinger, Lars Bullinger, Roland Goldbrunner, Alok A. Khorana, Manmeet Singh Ahluwalia, Frederick R. Rickles, Gary H. Lyman, and Peter Vajkoczy. “CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV.” In Journal of Clinical Oncology, 33:TPS2079–TPS2079. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.tps2079.
Kuhn SA, Marosi C, Pabinger I, Bullinger L, Goldbrunner R, Khorana AA, et al. CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. TPS2079–TPS2079.
Kuhn, Susanne Antje, et al. “CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. TPS2079–TPS2079. Crossref, doi:10.1200/jco.2015.33.15_suppl.tps2079.
Kuhn SA, Marosi C, Pabinger I, Bullinger L, Goldbrunner R, Khorana AA, Ahluwalia MS, Rickles FR, Lyman GH, Vajkoczy P. CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. TPS2079–TPS2079.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2015
Volume
33
Issue
15_suppl
Start / End Page
TPS2079 / TPS2079
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences